Authors: Kuppen, PJK van der Eb, MM Jonges, LE Hagenaars, M Hokland, ME Nannmlark, U Goldfarb, RH Basse, PH Fleuren, GJ Hoeben, RC van de Velde, CJH

Citation: Pjk. Kuppen et al., Tumor structure and extracellular matrix as a possible barrier for therapeutic approaches using immune cells or adenoviruses in colorectal cancer, HISTOCHEM C, 115(1), 2001, pp. 67-72

Authors: Jonges, LE Albertsson, P Van Vlierberghe, RLP Ensink, NG Johannson, BR Van de Velde, CJH Fleuren, GJ Nannmark, U Kuppen, PJK

Citation: Le. Jonges et al., The phenotypic heterogeneity of human natural killer cells: Presence of atleast 48 different subsets in the peripheral blood, SC J IMMUN, 53(2), 2001, pp. 103-110

Authors: Jonges, LE Nagelkerke, JF Ensink, NG van der Velde, EA Tollenaar, RAEM Fleuren, GJ van de Velde, CJH Morreau, H Kuppen, PJK

Citation: Le. Jonges et al., Caspase-3 activity as a prognostic factor in colorectal carcinoma, LAB INV, 81(5), 2001, pp. 681-688

Authors: Geutskens, SB van der Eb, MM Plomp, AC Jonges, LE Cramer, SJ Ensink, NG Kuppen, PJK Hoeben, RC

Citation: Sb. Geutskens et al., Recombinant adenoviral vectors have adjuvant activity and stimulate T cellresponses against tumor cells, GENE THER, 7(16), 2000, pp. 1410-1416

Authors: Jonges, LE Giezeman-Smits, KM van Vlierberghe, RLP Ensink, NG Hagenaars, M Joly, E Eggermont, AMM van de Velde, CJH Fleuren, GJ Kuppen, PJK

Citation: Le. Jonges et al., NK cells modulate MHC class I expression on tumor cells and their susceptibility to lysis, IMMUNOBIOL, 202(4), 2000, pp. 326-338

Authors: Hagenaars, M Ensink, NG Jonges, LE Chambers, WH Eggermont, AMM van de Velde, CJH Fleuren, GJ Kuppen, PJK

Citation: M. Hagenaars et al., The development of a bi-specific anti-CD 161AxAnti-tumor antibody for rat NK cell targeting, IMMUNOBIOL, 200(1), 1999, pp. 31-48